/Labcorp%20office%20in%20San%20Diego%2C%20CA%2C%20USA_BY%20JHVEphot.jpeg)
Labcorp Holdings Inc. (LH) is a global life sciences company providing comprehensive clinical laboratory and drug development services. Headquartered in Burlington, North Carolina, it operates diagnostics and biopharma segments and serves physicians, hospitals, pharmaceutical firms, and patients worldwide with routine, specialty, and central lab testing. The company has a market capitalization of $27.39 billion.
Better‑than‑expected results and improving profitability have supported Labcorp’s stock. Over the past 52 weeks, the stock has gained 22.3%. This year, the stock is up 34.6%. It reached a 52-week high of $339.76 on Aug. 25, and is down only marginally from that level.
